• Industry News
  • Law & Malpractice
  • Coding & Documentation
  • Practice Management
  • Finance
  • Technology
  • Patient Engagement & Communications
  • Billing & Collections
  • Staffing & Salary

EHR Funds Could Boost Handheld Device Use

Article

It looks like federal stimulus dollars will do more than encourage EHR use. The incentives could also drive the growth of handheld devices in healthcare, according to a new report.

It looks like federal stimulus dollars will do more than encourage EHR use. The incentives could also drive the growth of handheld devices in healthcare, according to a new report.

Handheld device sales for healthcare are expected to increase by 7 percent for the next five years as docs and hospitals buy new IT systems, according to “Handhelds in Healthcare: The World Market for PDAs, Tablet PCs, Handheld Monitors & Scanners,” the report from market researcher Kalorama Information. Sales reached $8.2 billion globally in 2009.

"The ARRA incentives for electronic medical records do not specifically reimburse doctors for devices," said Bruce Carlson, publisher of Kalorama Information. "But they are getting healthcare organizations to think about IT purchases, and they are helping to make the argument for better electronic data entry, something that we think will lead to increased sales for devices used to enter data."

Other factors that will boost handheld sales are a growing an aging population, a shortage of qualified medical professionals, cost restraints, and efforts to reduce medical errors, the report finds. Plus, the willingness of physicians and nurses to use handheld devices is growing. Patient monitoring devices dominate sales in that market, but administrative devices and tablet PCs are growing.
 

Any plans to invest in handheld devices, or are you already using one/some?

Related Videos
The importance of vaccination
The fear of inflation and recession
Protecting your practice
Protecting your home, business while on vacation
Protecting your assets during the 100 deadly days
Payment issues on the horizon
The future of Medicare payments
MGMA comments on automation of prior authorizations
The burden of prior authorizations
Strategies for today's markets
© 2024 MJH Life Sciences

All rights reserved.